Paloma Partners’s AtriCure ATRC Stock Holding History

Paloma Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,642	Closed	-$239K	–	1117
2022 Q1	$239K	Buy	+3,642	New	+$236K	0.01%	1293
2020 Q4	–	Sell	-7,360	Closed	-$294K	–	1636
2020 Q3	$294K	Buy	+7,360	New	+$312K	0.01%	1492
2019 Q2	–	Sell	-10,134	Closed	-$271K	–	1715
2019 Q1	$271K	Buy	+10,134	New	+$308K	0.01%	1356
2014 Q4	–	Sell	-14,474	Closed	-$213K	–	1152
2014 Q3	$213K	Buy	+14,474	New	+$231K	0.01%	829

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Paloma Partners's ATRC Position: Q2 2022 in Review

Paloma Partners sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 3,642 shares — an estimated $239K sold.

Paloma Partners first reported a position in ATRC in Q3 2014 and held it in 4 quarters. The position peaked at $294K in Q3 2020. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

Paloma Partners reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 3,642 AtriCure shares in Q2 2022, an estimated $239K.
Paloma Partners first reported a position in AtriCure in Q3 2014 and held it in 4 quarters.
Paloma Partners's AtriCure position peaked at $294K in Q3 2020.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.